Heterocyclic protein kinase inhibitors and uses thereof
US7244735B2 · kind B2 · utility
29Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2004 |
| Grant date | Jul 17, 2007 |
| Priority date | — |
| Expiry date | Dec 2, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds that are useful as protein kinase inhibitors of formula I:or a pharmaceutically acceptable salt thereof, wherein Ring B, Z1, Z2, U, p, Q, R1, R2, R3, and R3 are as defined herein. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplantation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.